Lataa...
A Framework for Treatment Decision Making at Prostate Cancer Recurrence
BACKGROUND: Of the 50,000 men in the US who elect radical prostatectomy for prostate cancer, 24–40% will have a prostate-specific antigen (PSA) recurrence (PSA-R) within 10 years. Deciding whether to administer salvage therapy (ST) at PSA-R presents challenges, as treatment reduces risk of progressi...
Tallennettuna:
| Julkaisussa: | Med Decis Making |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5632112/ https://ncbi.nlm.nih.gov/pubmed/28564551 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0272989X17711913 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|